Applicant(s)
- Novartis Pharmaceuticals Australia Pty Ltd
Notification number(s)
- N98692
Summary
Novartis will supply a range of services under its Pathway Program on condition that patients purchase Glivec of Tasigna prescribed by their treating physician through APG Cooleman Pty Ltd (APG).